South Phoenix Dialysis (DSI) in Phoenix, Arizona - Dialysis Center

South Phoenix Dialysis (DSI) is a medicare approved dialysis facility center in Phoenix, Arizona and it has 20 dialysis stations. It is located in Maricopa county at 4621 S Central Ave, Phoenix, AZ, 85040. You can reach out to the office of South Phoenix Dialysis (DSI) at (602) 304-1977. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. South Phoenix Dialysis (DSI) has the following ownership type - Profit. It was first certified by medicare in June, 2000. The medicare id for this facility is 032583 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameSouth Phoenix Dialysis (DSI)
Location4621 S Central Ave, Phoenix, Arizona
No. of Dialysis Stations 20
Medicare ID032583
Managed ByIndependent
Ownership TypeProfit
Late Shifts No

Contact Information


4621 S Central Ave, Phoenix, Arizona, 85040
(602) 304-1977

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with South Phoenix Dialysis (DSI) from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1588947048
Organization NameU.s. Renal Care South Phoenix Dialysis
Doing Business AsDialysis Newco Inc
Address4621 S Central Ave Phoenix, Arizona, 85040
Phone Number(602) 304-1977

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago


NPI Number1891740106
Organization NameNri Phoenix South
Doing Business AsDsi Renal Inc
Address4621 S Central Ave Phoenix, Arizona, 85040
Phone Number(602) 304-1977

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data25
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL16

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center58
    Adult patient months included in Kt/V greater than or equal to 1.2488
    Percentage of adult patients getting regular hemodialysis at the center93
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

    Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

    Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

    Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

    Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

    A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

    Study supports guidelines for treatment of aortic regurgitation

    Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

    UCL scientists find new way to artificially control paralyzed muscles using light

    ​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

    Read more Medical News

    › Verified 8 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at South Phoenix Dialysis (DSI) with elevated calcium levels.

Patients with hypercalcemia60
Hypercalcemia patient months494
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor58
Patients with Serumphosphor less than 3.5 mg/dL8
Patients with Serumphosphor from 3.5 to 4.5 mg/dL22
Patients with Serumphosphor from 4.6 to 5.5 mg/dL29
Patients with Serumphosphor from 5.6 to 7 mg/dL29
Patients with Serumphosphor greater than 7 mg/dL12

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 55
Patient months included in arterial venous fistula and catheter summaries 332
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment81
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer6

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary39
Hospitalization Rate in facility223.7 (As Expected)
Hospitalization Rate: Upper Confidence Limit398.2
Hospitalization Rate: Lower Confidence Limit130.9

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at South Phoenix Dialysis (DSI) were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility17.2 (As Expected)
Readmission Rate: Upper Confidence Limit30.9
Readmission Rate: Lower Confidence Limit7.9

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at South Phoenix Dialysis (DSI) get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility.32 (As Expected)
SIR: Upper Confidence Limit1.57
SIR: Lower Confidence Limit.02

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether South Phoenix Dialysis (DSI)'s rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 38
Transfusion Rate in facility42 (As Expected)
Transfusion Rate: Upper Confidence Limit121.7
Transfusion Rate: Lower Confidence Limit16.5

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at South Phoenix Dialysis (DSI) lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary259
Mortality Rate in facility23.2 (As Expected)
Mortality Rate: Upper Confidence Limit32.1
Mortality Rate: Lower Confidence Limit16.2

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago


Dialysis Facility in Phoenix, AZ

Maricopa Medical Ctr - Dialysis
Location: 2525 E Roosevelt St, Phoenix, Arizona, 85008
Phone: (602) 344-1601
South Phoenix Dialysis Services (FMC)
Location: 1021 S 7th Ave Ste 108, Phoenix, Arizona, 85007
Phone: (602) 253-1954
Central Phx Dialysis (FMC)
Location: 3421 N 7th Ave, Phoenix, Arizona, 85013
Phone: (602) 274-2293
Desert Valley Dialysis (FMC)
Location: 15846 N Cave Creek Rd Ste 2, Phoenix, Arizona, 85032
Phone: (602) 971-4555
Estrella Dialysis Center (FMC)
Location: 5546 W Roosevelt St Ste 1, Phoenix, Arizona, 85043
Phone: (602) 352-0724

News Archive

Intuitive Surgical and Trumpf Medical team up to address hospitals' need for operating room integration

Intuitive Surgical and Trumpf Medical are now offering Integrated Table Motion for the da Vinci® Xi® Surgical System in Europe. This first-of-its-kind product includes the latest Intuitive Surgical robotic-assisted surgical system and Trumpf Medical's advanced operating table, the TruSystem® 7000dV. The surgical system and table have been seamlessly integrated to allow surgeons and anesthesiologists – for the first time – to make a comprehensive range of table adjustments easily and efficiently during da Vinci Surgery.

Digna Biotech, CIMA receive EU grant for development of gene therapy product for Acute Intermittent Porphyria

Digna Biotech and the Centro de Investigacion Medica Aplicada (CIMA) de la Universidad de Navarra announced today that the European Union (EU) has finalized a EUR 3.3 million grant to AIPGENE consortium. Digna Biotech and CIMA will receive, as members of the consortium, EUR 0.5 and EUR 0.8 million respectively for the clinical development of a gene therapy product for Acute Intermittent Porphyria (AIP).

Hydroxyurea plus aspirin best therapy in patients with essential thrombocythemia who are at high risk for vascular events

A new treatment for an incurable blood disorder proves a worse option for patients' health than an older treatment, according to a study to be presented today during the 46th Annual Meeting of the American Society of Hematology (ASH).

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

UCL scientists find new way to artificially control paralyzed muscles using light

​A new way to artificially control muscles using light, with the potential to restore function to muscles paralysed by conditions such as motor neuron disease and spinal cord injury, has been developed by scientists at UCL and King's College London.

Read more Medical News

› Verified 8 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.